The efficacy and tolerability of transarterial chemo-embolization (TACE) compared with transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)

被引：7
|
作者：
Hanks, B. A.
Suhocki, P. V.
DeLong, D. M.
Doan, P. L.
Liu, E.
Tsai, A. L.
Burke, C. T.
Bernard, S. A.
O'Neil, B. H.
Morse, M. A.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4595
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Longitudinal monitoring of cell-free DNA to predict for transarterial chemo-embolization failure in hepatocellular carcinoma.
    Evans, Joanne
    Ward, Caroline
    Pai, Madhava
    Sharma, Rohini
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization
    Lanza, Ezio
    Muglia, Riccardo
    Bolengo, Isabella
    Poretti, Dario
    D'Antuono, Felice
    Ceriani, Roberto
    Torzilli, Guido
    Pedicini, Vittorio
    PLOS ONE, 2020, 15 (01):
  • [23] Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
    Lanza, Ezio
    Masetti, Chiara
    Messana, Gaia
    Muglia, Riccardo
    Pugliese, Nicola
    Ceriani, Roberto
    de Nalda, Ana Lleo
    Rimassa, Lorenza
    Torzilli, Guido
    Poretti, Dario
    D'Antuono, Felice
    Politi, Letterio Salvatore
    Pedicini, Vittorio
    Aghemo, Alessio
    PLOS ONE, 2020, 15 (06):
  • [24] Transarterial chemoembolization (TACE) in patients with unresectable diffuse vs. focal hepatocellular carcinoma (HCC).
    Pan, SH
    Ramirez, C
    Hoffman, A
    Sher, L
    Rojter, S
    Lopez, RR
    GASTROENTEROLOGY, 2000, 118 (04) : A991 - A991
  • [25] TRANSARTERIAL (CHEMO-)EMBOLIZATION VERSUS SORAFENIB IN PATIENTS WITH ADVANCED STAGE HEPATOCELLULAR CARCINOMA
    Pinter, Matthias
    Hucke, Florian
    Graziadei, Ivo
    Maieron, Andreas
    Koenigsberg, Robert
    Stauber, Rudolf E.
    Gruenberger, Birgit
    Mueller, Christian
    Koelblinger, Claus
    Peck-Radosavljevic, Markus
    Sieghart, Wolfgang
    HEPATOLOGY, 2011, 54 : 1388A - 1388A
  • [26] Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
    Oliveri, Roberto S.
    Wetterslev, Jorn
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [27] Treatment of hepatocellular carcinoma by transarterial embolization (TAE). A prospective placebo controlled trial.
    Bruix, J
    Llovet, JM
    Castells, A
    Bru, C
    Montanya, X
    Vilana, R
    Ayuso, MC
    Rodes, J
    HEPATOLOGY, 1997, 26 (04) : 482 - 482
  • [28] Safety and efficacy of transarterial embolization of hepatocellular adenomas
    van Rosmaleni, B., V
    Klompenhouwer, A. J.
    de Graeff, J. Jaap
    Haring, M. P. D.
    de Meijer, V. E.
    Rifai, L.
    Dokmak, S.
    Rawashdeh, A.
    Abu Hilal, M.
    de Jong, M. C.
    Dejong, C. H. C.
    Doukas, M.
    de Man, R. A.
    IJzermans, J. N. M.
    van Delden, O. M.
    Verheij, J.
    van Gulikl, T. M.
    BRITISH JOURNAL OF SURGERY, 2019, 106 (10) : 1362 - 1371
  • [29] TRANSARTERIAL EMBOLIZATION (TAE) VS NO TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA (HCC) - PRELIMINARY-RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    CASTELLS, A
    BRUIX, J
    MONTANYA, X
    BRU, C
    AYUSO, MC
    BOIX, L
    RODES, J
    HEPATOLOGY, 1994, 19 (04) : I51 - I51
  • [30] Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
    Comito, Tiziana
    Loi, Mauro
    Franzese, Ciro
    Clerici, Elena
    Franceschini, Davide
    Badalamenti, Marco
    Teriaca, Maria Ausilia
    Rimassa, Lorenza
    Pedicini, Vittorio
    Poretti, Dario
    Solbiati, Luigi Alessandro
    Torzilli, Guido
    Ceriani, Roberto
    Lleo, Ana
    Aghemo, Alessio
    Santoro, Armando
    Scorsetti, Marta
    CURRENT ONCOLOGY, 2022, 29 (11) : 8802 - 8813
12345